PROMOGRAN MATRIX
Report
- Report Number
- 3007663067-2011-00004
- Event Type
- Other
- Date Received
- September 5, 2011
- Date of Event
- August 5, 2011
- Report Date
- September 5, 2011
- Manufacturer
- SYSTAGENIX WOUND MANAGEMENT MANUFACTURING LIMITED
- Product Code
- FRO
- PMA / PMN Number
- K014129
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- NOT APPLICABLE
Narratives
(B)(4). CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME. A REVIEW OF THE BATCH MFG RECORDS WAS CONDUCTED. THE BATCH MET ALL RELEASE CRITERIA. FOLLOWING THE CLEANING OF THE WOUND WITH STERILE WATER THE NURSE SAID SHE DIDN'T LIKE THE LOOKS OF THE WOUND BECAUSE YELLOW TISSUE HAD FORMED. THE NURSE DID NOT APPLY ANYTHING TO THE WOUND. OVER THE COURSE OF SEVERAL DAYS, THE WOUND GREW LARGER AND WAS MORE YELLOW IN COLOR. PT CONTINUED TO COMPLAIN OF PAIN AND PAIN HAD SPREAD TO THE PT'S TOE. ON (B)(6) (PT'S DAUGHTER) TOOK HER MOTHER TO THE ER OF THE HOSP. THE HOSP TOOK PT'S VITAL SIGNS AND A CULTURE OF THE WOUND. THEY ADVISE (B)(6) TO WASH THE WOUND TWICE A DAY AND ROLL A Q-TIP OVER THE YELLOW TISSUE. (B)(6) MENTIONED THAT WHEN PROMGRAN WAS FIRST APPLIED TO THE WOUND, THE WOUND HAD SLIGHT YELLOW TISSUE SHOWING.
NURSE PUT ON PT'S FOOT ULCER WOUND DRESSING MATRIX COVERED WITH MEPITEX TAPE. WITHIN 8 HRS, PT COMPLAINED OF BURNING. SHORTLY AFTER PT STATED SHE DID NOT FEEL WELL AND WAS DESCRIBED AS PALE IN COLOR, 10 HRS AFTER HAVING THE WOUND DRESSING MATRIX APPLIED, THE PT WAS IN SUCH PAIN HER DAUGHTER CALLED THE EMERGENCY NURSE. THEY DID NOT RESPOND UNTIL THE NEXT DAY WHEN 2 NURSES VISITED. AFTER REMOVING THE TAPE, IT WAS OBSERVED THAT THE WOUND DRESSING MATRIX HAD NOT DISSOLVED. APPROXIMATELY THE NEXT DAY, THE WOUND WAS CLEANED WITH STERILE WATER AND IT DISSOLVED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | PROMOGRAN MATRIX | WOUND DRESSING | FRO | SYSTAGENIX WOUND MANAGEMENT MANUFACTURING LIMITED | 1110/2/1/3 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 99 YR | Other |